SEARCH

SEARCH BY CITATION

  • 1
    Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E. L. and Taniguchi, T., Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 1989. 337: 270278.
  • 2
    Galon, J., Sudarshan, C., Ito, S., Finbloom, D. and O'Shea, J. J., IL-12 induces IFN regulating factor-1 (IRF-1) gene expression in human NK and T cells. J. Immunol. 1999. 162: 72567261.
  • 3
    Harada, H., Fujita, T., Miyamoto, M., Kimura, Y., Maruyama, M., Furia, A., Miyata, T. and Taniguchi, T., Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989. 4: 729734.
  • 4
    Miyamoto, M., Fujita, T., Kimura, Y., Maruyama, M., Harada, H., Sudo, Y., Miyata, T. and Taniguchi, T., Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements. Cell 1988. 54: 903909.
  • 5
    Lohoff, M., Ferrick, D., Mittrucker, H.-W., Duncan, G. S., Bischof, S., Rollinghoff, M. and Mak, T. W., Interferon regulator factor-1 is required for a T helper 1 immune response in vivo. Immunity 1997. 6: 681689.
  • 6
    Tada, Y., Ho, A., Matsuyama, T. and Mak, T. W., Reduced incidence and severity of antigen-induced autoimmune diseases in mice lacking interferon regulatory factor-1. J. Exp. Med. 1997. 185: 231238.
  • 7
    Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C. and Strober, W., Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion ofIL-5. J. Immunol. 1996. 157: 12611270.
  • 8
    Plevy, S. E., Landers, C. J., Prehn, J., Carramanzana, N. M., Deem, R. L., Shealy, D. and Targan, S. R., A role for TNF-α and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease. J. Immunol. 1997. 159: 62766282.
  • 9
    Kelley, T. J. and Elmer, H. L., In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. J. Clin. Invest. 2000. 106: 403410.
  • 10
    Ohteki, T., Yoshida, H., Matsuyama, T., Duncan, G. S., Mak, T. W. and Ohashi, P. S., The transcription factor interferon regulatory factor 1 (IRF-1) is important during the maturation of natural killer 1.1+ T cell receptor-α/β+ (NK1+ T) cells, natural killer cells, and intestinal intraepithelial T cells. J. Exp. Med. 1998. 187: 967972.
  • 11
    Penninger, J. M., Sirard, C., Mittrucker, H. W., Chidgey, A., Kozieradzki, I., Nghiem, M., Hakem, A., Kimura, T., Timms, E., Boyd, R. et al., The interferon regulatory transcription factor IRF-1 controls positive and negative selection of CD8+ thymocytes. Immunity 1997. 7: 243254.
  • 12
    Taki, S., Sato, T., Ogasawara, K., Kukuda, T., Sato, M., Hida, S., Suzuki, G., Mitsuyama, M., Shin, E. H., Kojima, S. et al., Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997. 6: 673680.
  • 13
    Fantuzzi, G., Reed, D. A., Qi, M., Dinarello, C. A. and Senaldi, G., Role of interferon regulatory factor-1 in the regulation of IL-18 production and activity. Eur. J. Immunol. 2001. 31: 369375.
  • 14
    Hurgin, V., Novick, D. and Rubinstein, M., The promoter of IL-18 binding protein; activation byan IFN-γ-induced complex of IFN regulatory factor 1 and CCAT/enhancer binding protein β. Proc. Nat. Acad. Sci. USA 2002. 99: 1695716962.
  • 15
    Liu, J., Cao, S., Herman, L. M. and Ma, X., Differential regulationof interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-γ primed IL-12 production by IFN regulatory factor 1. J. Exp. Med. 2003. 198: 12651276.
  • 16
    Ogasawara, K., Hida, S., Azimi, N., Tagaya, Y., Sato , T., Yokochi-Fukuda, T., Waldmann, T. A., Taniguchi, T. and Taki, S., Requirement for IRF-1 in the microenvironment supporting development of natural killer cells. Nature 1998. 391: 700703.
  • 17
    Okayasu, I., Hatakeyama, S., Yamada, M., Okhusa, T., Inagaki, Y. and Nakaya, R., A novel method for the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990. 98: 694702.
  • 18
    Strober, W., Fuss, I. J. and Blumberg, R. S., The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 2002. 20: 495549.
  • 19
    Siegmund, B., Lehr, H. A. and Fantuzzi, G., Leptin: a pivotal mediator of intestinal inflammation. Gastroenterology 2002. 122: 20112025.
  • 20
    Taniguchi, T., Ogasawara, K., Takaoka, A. and Tanaka, N., IRF family of transcription factors as regulators of host defense. Annu. Rev. Immunol. 2001. 19: 623655.
  • 21
    Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K. et al., Cis3/socs3/ssi3 plays a negative regulatory role in stat3 activation and intestinal inflammation. J. Exp. Med. 2001. 193: 471482.
  • 22
    Hans, W., Scholmerich, J., Gross, V. and Falk, W., Interleukin-12 induced interferon-γ increases inflammation in acute dextran sulfate sodium induced colitis in mice. Eur. Cytokine Netw. 2000. 11: 6774.
  • 23
    Chen, Y., Chou, K., Fuchs, E., Havran, W. L. and Boismenu, R., Protection of the intestinal mucosa by intraepithelial γ δ T cells. Proc. Natl. Acad. Sci. U S A 2002. 99: 1433814343.
  • 24
    Tsuchiya, T., Fukuda, S., Hamada, H., Nakamura, A., Kohama, Y., Ishikawa, H., Tsujikawa, K. and Yamamoto, H., Role of γ δ T cells in the inflammatory response of experimental colitis mice. J. Immunol. 2003. 171: 55075513.
  • 25
    Siegmund, B., Fantuzzi, G., Rieder, F., Gamboni-Robertson, F., Lehr, H. A., Hartmann, G., Dinarello, C. A., Endres, S. and Eigler, A., Neutralization of IL-18 reduces severity in murine colitis and intestinal IFN-γ and TNF-α production. Am. J. Physiol. 2001. 281: R1264-R1273.
  • 26
    Ten Hove, T., Corbaz, A., Amitai, H., Aloni, S., Belzer, I., Graber, P., Drillenburg, P., van Deventer, S. J., Chvatchko, Y. and Te Velde, A. A., Blockade of endogenous IL-18 ameliorates TNBS-induced colitis by decreasing local TNF-α production in mice. Gastroenterology 2001. 121: 13721379.
  • 27
    Sivakumar, P. V., Brown, S. N., Goldrath, A. W., van der Vuurst de Vries, A. R., Viney, J. L. and Kennedy, M. K., IL-15. Insights from characterizing IL-15-deficient mice. In Fantuzzi, G. (Ed.) Cytokine Knockouts , 2nd Edition. Humana Press, Totowa, NJ, USA 2003, pp 281301.
  • 28
    Senaldi, G., Shaklee, C. L., Guo, J., Martin, L., Boone, T., Mak, T. W. and Ulich, T. R., Protection against the mortality associated with disease models mediated by TNF and IFN-γ in mice lacking IFN regulatory factor-1. J. Immunol. 1999. 163: 68206826.
  • 29
    Krieglstein, C. F., Cerwinka, W. H., Laroux, F. S., Salter, J. W., Russell, J. M., Schuermann, G., Grisham, M. B., Ross, C. R. and Granger, D. N., Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J. Exp. Med. 2001. 194: 12071218.
  • 30
    Morteau, O., Morham, S. G., Sellon, R. K., Dieleman, L. A., Langenbach, R., Smithies, O. and Sartor, S. B., Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cylooxygenase-2. J. Clin. Invest. 2000. 105: 469478.
  • 31
    Blanco, J. C., Contursi, C., Salkowski, C. A., DeWitt, D. L., Ozato, K. and Vogel, S. N., Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression. J. Exp. Med. 2000. 191: 21312144.
  • 32
    Ashkar, A. A., Black, G. P., Wei, Q., He, H., Liang, L., Head, J. R. and Croy, B. A., Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J. Immunol. 2003. 171: 29372944.
  • 33
    Meijssen, M. A., Brandwein, S. L., Reinecker, H. C., Bhan, A. K. and Podolsky, D. K., Alteration of gene expression by intestinal epithelial cells precedes colitis in interleukin-2-deficient mice. Am. J. Physiol. 1998. 274: G472-G479.
  • 34
    Powrie, F., Leach, M. W., Mauze, S., Menon, S., Barcomb Caddle, L. and Coffman, R. L., Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ cells. Immunity 1994. 1: 553562.
  • 35
    Camoglio, L., Te Velde, A. A., de Boer, A., ten Kate, F. J., Kopf, M. and van Deventer, S. J., Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-γ receptor-deficient mice. Eur. J. Immunol. 2000. 30: 14861495.
    Direct Link:
  • 36
    Mizoguchi, A., Mizoguchi, E. and Bhan, A. K., The critical role of interleukin-4 but not interferon γ in the pathogenesis of colitis in T-cell receptor α-mutant mice. Gastroenterology 1999. 116: 320326.
  • 37
    Davidson, N. J., Hudak, S. A., Lesley, R. E., Menon, S., Leach, M. W. and Rennick, D. M., IL-12, but not IFNγ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Immunol. 1998. 161: 31433149.
  • 38
    Hoffmann, J. C., Peters, K., Henschke, S., Herrmann, B., Pfister, K., Westermann, J. and Zeitz, M., Role of T lymphocytes in rat 2,4,6-trinitrobenzene sulphonic acid (TNBS) induced colitis: increased mortality after γ δ T cell depletion and no effect of α β T cell depletion. Gut 2001. 48: 489495.
  • 39
    Corbaz, A., ten Hove, T., Herren, S., Graber, P., Schwartsburd, B., Belzer, I., Harrison, J., Plitz, T., Kosco-Vilbois, M. H., Kim, S. H. et al., IL-18-binding protein expression by endothelial cells and macrophages is up-regulated during active Crohn's disease. J. Immunol. 2002. 168: 36083616.
  • 40
    Pizarro, T. T., Michie, M. H., Bentz, M., Woraratanadharm, J., Smith, M. F., Foley, E., Moskaluk, C. A., Bickston, S. J. and Cominelli, F., IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells. J. Immunol. 1999. 162: 68296835.
  • 41
    Wirtz, S., Becker, C., Blumberg, R. S., Galle, P. R. and Neurath, M., Treatment of T cell-dependent experimental colitis in SCID mice by local administration of an adenovirus expressing IL-18 antisense mRNA. J. Immunol. 2002. 168: 411420.
  • 42
    Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kundig, T. M., Amakawa, R., Kishihara, K., Wakeham, A. et al., Targeted disruption of IRF-1 and IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993. 75: 8390.
  • 43
    Wieland, C. W., Siegmund, B., Senaldi, G., Vasil, M. L., Dinarello, C. A. and Fantuzzi, G., Pulmonary inflammation induced by Pseudomonas aeuriginosa lipopolysaccharide, phospholipase C and exotoxin A: role of interferon regulatory factor 1. Infect. Immun. 2002. 70: 13521358.
  • 44
    Fantuzzi, G., Reed, D. A. and Dinarello, C. A., Interleukin (IL)-12-induced interferon-γ is dependent on caspase-1 processing of the IL-18 precursor. J. Clin. Invest. 1999. 104: 761767.